Glaxo given $6.7m for malaria vaccine
A non-profit organisation is paying GlaxoSmithKline $6.7m to speed up the development of a malaria vaccine candidate that has been in development since
A non-profit organisation is paying GlaxoSmithKline $6.7m to speed up the development of a malaria vaccine candidate that has been in development since